CE mark for Trajan’s hemaPEN blood microsampling device, now available for diagnostic use across EU and UK

CE mark for Trajan’s hemaPEN blood microsampling device, now available for diagnostic use across EU and UK

May 07, 2020

Trajan Scientific and Medical (Trajan) has declared hemaPEN® compliance with EU IVD Directive 98/79/EC, and its release for in vitro diagnostic use in the EU and UK. This follows the hemaPEN’s recent addition to the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class 1 IVD device.

This enables hemaPEN to be used to collect blood microsamples for clinical trials, diagnostics and applications to monitor health.

hemaPEN provides a convenient sampling procedure for collection and storage of four dried blood spot (DBS) samples. Unlike conventional DBS sampling tools, hemaPEN enables collection of an accurate and precise fixed micro-volume and is designed to maintain sample integrity for quantitative analysis. An easy-to-use sophisticated microsampling tool in the hands of non-analysts.

In today’s environment, where whole communities are practising self-isolation due to COVID-19, remote microsampling facilitates ongoing blood monitoring of chronic disease, and enables continuity-of-care for vulnerable members of society.

Trajan’s CEO, Mr Stephen Tomisich said, “This is the tipping point for remote microsampling technology; alongside e-health consultations and e-prescription we are moving to a more remote healthcare system.”

Dr Anne Collins, Trajan’s Business Unit General Manager, Microsampling, said, “hemaPEN’s adoption in ongoing medical treatment and monitoring would remove the need for travel, reduce pressure on healthcare workers, and eliminate expensive cold chain logistics.”

Trajan believes in science that benefits people – creating portable and affordable measurement solutions, enabling accurate results to inform preventative healthcare.

Visit www.hemapen.com to purchase or learn more about hemaPEN, and to sign up for updates.

To learn more about Trajan’s microsampling technologies and capabilities visit www.trajanscimed.com/microsampling.




Also in News

New Trajan microtome blades, for any tissue type
New Trajan microtome blades, for any tissue type

April 28, 2020

Trajan Scientific and Medical releases new microtome blades in Australia, New Zealand, UK and EU, to provide the blade of choice for any tissue type. For histologists who have trouble finding a blade that offers both exceptional cutting and longevity, Trajan microtome blades have been designed to enable smooth and precise sectioning across a wide range of tissue specimens.

Read More

The third leg in at-home healthcare – microsampling
The third leg in at-home healthcare – microsampling

April 16, 2020

Blood microsampling technology has been evolving over the past few years. Designed to cut the need for central pathology collection centers and trained phlebotomists. It enables the collection of very small, accurate blood samples in the home.

Read More

Trajan and Queen’s University awarded Mitacs grant to develop MES technology for mass spectrometry
Trajan and Queen’s University awarded Mitacs grant to develop MES technology for mass spectrometry

March 03, 2020

Trajan Scientific and Medical and Queen’s University, Kingston, Canada, have been awarded a Mitacs Accelerate grant to develop new multiple electrospray (MES) technologies to increase throughput and sensitivity in mass spectrometry (MS).

Read More